Necrosis Clinical Trials

Find Necrosis Clinical Trials Near You

The Role of Dry Needling Therapy and Low-Level Laser Microcurrent Electrical Stimulation on Serum Levels of Tumor Necrosis Factor-alpha (TNF-α) and Malondialdehyde (MDA) in Myofascial Pain Syndrome

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to evaluate the effectiveness of dry needling and Low-Level Laser Microcurrent Electrical Stimulation (LL MCES) in patients with acute upper trapezius myofascial pain syndrome (MPS) by assessing both biological and clinical outcomes. Specifically, it investigates whether these interventions reduce serum levels of the inflammatory biomarker tumor necrosis factor-alpha (TNF-α) and the oxidative stress biomarker malondialdehyde (MDA), while also improving pain intensity and neck-related disability. The study seeks to address the current knowledge gap regarding the relationship between changes in inflammatory and oxidative stress biomarkers and clinical improvement following these non-pharmacological treatments. The primary research question is: Do dry needling and LL MCES reduce serum TNF-α and MDA levels and improve clinical outcomes in patients with acute upper trapezius myofascial pain syndrome? Participants will: Be randomly assigned to receive dry needling, LL MCES, combined dry needling and LL MCES, or sham dry needling. Receive treatment according to the assigned intervention protocol. Undergo blood sampling before and after the intervention to measure serum TNF-α and MDA levels. Complete assessments of pain intensity using the Numerical Pain Rating Scale (NPRS) and neck-related disability using the Neck Disability Index (NDI) before and after treatment. Attend scheduled follow-up visits for clinical evaluation and outcome assessment.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 45
Healthy Volunteers: f
View:

• Participants must meet all of the following criteria:

⁃ Adults aged 20 to 45 years. Clinical diagnosis of acute upper trapezius myofascial pain syndrome (MPS) with symptom duration of less than 1 month.

⁃ Presence of at least one active myofascial trigger point in the upper trapezius muscle confirmed by physical examination according to accepted diagnostic criteria (palpable taut band, hypersensitive trigger point, reproduction of the patient's typical pain, and/or local twitch response).

⁃ Moderate or greater neck pain (Numerical Pain Rating Scale \[NPRS\] ≥4). Willing and able to provide written informed consent and comply with study procedures.

Locations
Other Locations
Indonesia
Udayana University
RECRUITING
Denpasar
Contact Information
Primary
I Putu Eka Widyadharma, MD, PhD
eka.widyadharma@unud.ac.id
+62 812-3787-2840
Time Frame
Start Date: 2026-07-30
Estimated Completion Date: 2027-02-28
Participants
Target number of participants: 80
Treatments
Experimental: Dry Needling Group
Participants receive dry needling treatment targeting active myofascial trigger points in the upper trapezius muscle according to the study protocol.
Experimental: Low-Level Laser Microcurrent Electrical Stimulation (LL MCES)
Participants receive LL MCES therapy applied to the upper trapezius trigger point region according to the study protocol.
Experimental: Combined Dry Needling + LL MCES
Participants receive both dry needling and LL MCES during the same treatment session according to the study protocol.
Sham_comparator: Sham Dry Needling
Participants receive a sham dry needling procedure designed to mimic the treatment experience without therapeutic needle penetration of the trigger point.
Related Therapeutic Areas
Sponsors
Leads: Udayana University

This content was sourced from clinicaltrials.gov